Papers/PMID:33266487
Dietary Acrylamide Intake and the Risk of Pancreatic Cancer: The Japan Public Health Center-Based Prospective Study.
Nutrients2020The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
acrylamide — no detected effect on pancreatic cancer incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“We observed no association between dietary acrylamide intake and pancreatic cancer (Table 2).”
Quoted verbatim from Dietary Acrylamide Intake and the Risk of Pancreatic Cancer: The Japan Public Health Center-Based Prospective Study.. - Study
- cohort
- Population
- 89,729 Japanese men and women aged 45-74 years without prior cancer (JPHC Study), energy-adjusted dietary acrylamide intake by quartile, mean follow-up 15.2 years; whole-cohort result
Dietary Acrylamide Intake and the Risk of Pancreatic Cancer: The Japan Public Health Center-Based Prospective Study.2020PMID:33266487Permalink